Overview

Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if memantine is effective in treating symptoms of Fragile X-associated Tremor Ataxia Syndrome.
Phase:
N/A
Details
Lead Sponsor:
University of California, Davis
Collaborators:
Forest Laboratories
National Institute on Aging (NIA)
Treatments:
Memantine